Navigation Links
Cell Therapeutics Reaches Agreement to Reacquire Rights to Two Anti-Cancer Compounds
Date:1/13/2014

SEATTLE, Jan. 13, 2014 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that it has reached an agreement with Novartis to reacquire rights to two anti-cancer compounds -- pixantrone (PIXUVRI®) and paclitaxel poliglumex (Opaxio™). Under the terms of the previous agreement, CTI has been responsible for development and commercialization activities and expenses for both compounds to date.  Upon the effective date of termination, CTI will regain all rights that had been granted to Novartis.  In exchange for Novartis' agreement to return such rights to CTI, CTI has agreed to make certain potential payments to Novartis based on sales of Opaxio and PIXUVRI and on any sublicense and certain other amounts payable to CTI.  

"We are pleased that Novartis and CTI were able to reach a mutually beneficial agreement regarding rights to PIXUVRI and Opaxio," stated James A. Bianco, M.D., CTI's President and CEO. "Regaining full rights to these two anti-cancer agents -- one currently marketed in Europe and the other completing late-stage development -- provides us with the flexibility to manage these assets within the context of our overall product portfolio strategy. PIXUVRI is a first-in-class aza-anthracenedione with unique structural and physiochemical properties and the first approved therapy in the European Union for the treatment of patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Opaxio is completing Phase 3 development as maintenance therapy in patients with ovarian cancer and is also being studied in Phase 2 trials for patients with malignant brain cancer. We believe these drugs could have an important impact in the treatment of patients with cancer."

About PIXUVRI

PIXUVRI® (pixantrone) is a novel aza-anthracenedione with un
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
2. PhaseRx Appoints Michael Houston, Ph.D., Vice President, Therapeutics Development
3. ImmunoCellular Therapeutics Issues Shareholder Letter Providing Update on ICT-107 Program in Newly Diagnosed Glioblastoma
4. Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa for distal ulcerative colitis
5. Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy and Immunosuppressants) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018
6. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
7. Flexion Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. G1 Therapeutics to Present at Biotech Showcase 2014
9. Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics
10. Mast Therapeutics Provides Enrollment Update On Phase 3 "EPIC" Study Of MST-188
11. Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , 11. Juli 2014  Dilon ... für die molekulare Bildgebung, einschließlich molekularer ... die CE-Zulassung für sein Navigator ® ... Dilon das Produkt jetzt europaweit vertreiben. ... Großteil der europäischen Länder ausgedehnt und ...
(Date:7/10/2014)... Calif. , July 10, 2014  Breg, ... and services, has launched the FreeRunner™ knee brace ... who suffer from patella mal-tracking return to active ... differently than other braces, providing support when patients ... normally when they don,t. Patellofemoral issues ...
(Date:7/10/2014)... July 10, 2014  RESMED INC. (NYSE: RMD ... and fiscal year ended June 30, 2014 results on Thursday, ... close. A press release with ResMed,s results will be issued ... host a webcast to discuss operating results and future outlook. ... 1:30 p.m. US Pacific Time and the live webcast of ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... BioTrends Research Group, Inc. recently published its ... is based on online survey ... radiologists and interventional nephrologists). It provides an in-depth view ... patterns related to both vascular access placement and maintenance. ...
... Aug. 24 Sunridge International (OTC Bulletin Board: ... next month to have meetings with key brokers and funds. ... to our company,s technology, and to facilitate funding for Sunridge ... "Now is a good time for this project," states G. ...
Cached Medicine Technology:Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market 2
(Date:7/11/2014)... New York (PRWEB) July 11, 2014 ... ) , filed against Johnson & Johnson’s Ethicon ... Bernstein Liebhard LLP notes that the Texas Attorney ... the company’s marketing of surgical mesh products used ... incontinence. According to a report from kens5.com, the ...
(Date:7/11/2014)... Dennis Thompson HealthDay Reporter ... born with HIV who was thought to be cured by ... showing detectable levels of the AIDS-causing virus in her bloodstream, ... nearly 4 years old, had remained virus-free even though she ... Doctors had hoped her remission would open the door to ...
(Date:7/11/2014)... 2014 The report, “Specialty Synthetic ... & Geography - 2018,” defines and segments the ... an analysis and forecast of the volumes and ... (Para aramids, meta aramids, UHMW Polyethylene, carbon fiber, ... fiber, PBI fiber, PBO fiber, and liquid crystal ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 ... least $50 billion in fuel costs now ... The current GHG standards are ... taken it upon themselves to install new ... , 1.    Idle reduction technologies , 2.    Efficient driveline ...
(Date:7/11/2014)... 2014 Ticket Down is a reliable ... . When it comes to the summer concert schedule, it ... Georgia native is one of the biggest names in country music ... is currently out on his “That’s My Kind of Night” tour ... tour will be making through the rest of the summer and ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3
... Set to Take Up Bill Which Includes Grants to,Train ... People,with Hearing Loss, VIENNA, Va., April 21 ... David Wu, D-Oregon, a,member of the House Subcommittee on ... in conference and vote to approve the,College Opportunity and ...
... suggests that teens may get addicted and relapse more ... motivated by drug-related cues. This conclusion has been reached ... a powerfully addicting stimulant were more likely ... it. That learned association endured: Even after experimenters ...
... of Funds in Ohio Sets Dangerous Precedent, ... preserve Ohio,s tobacco settlement dollars for their originally ... Franklin County Court of,Common Pleas for permission to ... funds, wisely dedicated by the State to,tobacco prevention ...
... leadership in premium and specialty paper market, ... that Boise BEWARE, its anti-copy/anti-scan paper, complies,with federal ... two tamper-resistant features. According to the federal mandate,for ... three,criteria by April 1. Medicaid prescription papers must ...
... April 21 NBTY, Inc. (NYSE:,NTY) (http://www.NBTY.com ), ... announced it will web cast a conference call,to review ... http://www.nbty.com on Friday, April 25, 2008 at 8:30 ... second quarter will be issued at 4:30 PM,(ET) on ...
... The National Council on Disability,(NCD) today ... Program,Performance Indicators,( http://www.ncd.gov/newsroom/publications/2008/Indicators_Report.html ),calling on the Federal ... federal data,describing the status of Americans with ... of a year-long effort. It describes what ...
Cached Medicine News:Health News:NCRA Urges Congressman David Wu to Approve in Conference the Higher Education Reauthorization Bill Providing Closed Captioning for 30 Million Deaf and Hard-of-Hearing Americans 2Health News:Rat study suggests why teens get hooked on cocaine more easily than adults 2Health News:Rat study suggests why teens get hooked on cocaine more easily than adults 3Health News:American Legacy Foundation Steps Forward to Fight For, Safeguard Ohio's Tobacco Settlement Dollars 2Health News:American Legacy Foundation Steps Forward to Fight For, Safeguard Ohio's Tobacco Settlement Dollars 3Health News:American Legacy Foundation Steps Forward to Fight For, Safeguard Ohio's Tobacco Settlement Dollars 4Health News:Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper 2Health News:Boise(R) BEWARE(R) Meets April 1 Federal Medicaid Guidelines Requiring Tamper-Resistant Prescription Paper 3Health News:NBTY to Web Cast Fiscal Second Quarter Conference Call 2Health News:National Council on Disability Recommends Improving Federal Data Describing the Status of Americans with Disabilities 2Health News:National Council on Disability Recommends Improving Federal Data Describing the Status of Americans with Disabilities 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: